Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort

Renato Mendes Rossi De Lucca , Danielle Barbosa Brotto , Claudia Tarcila Gomes Sares , Kelly Gomes Duarte , Wilson Araujo Silva Junior , Philippe E. Spiess , Shahrokh F. Shariat , Natália Dalsenter Avilez , Caio de Oliveira , Leonardo O. Reis , Rodolfo Borges dos Reis

Exploration of Targeted Anti-tumor Therapy ›› 2025, Vol. 6 ›› Issue (1) : 1002323

PDF (786KB)
Exploration of Targeted Anti-tumor Therapy ›› 2025, Vol. 6 ›› Issue (1) :1002323 DOI: 10.37349/etat.2025.1002323
Original Article
research-article
Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort
Author information +
History +
PDF (786KB)

Abstract

Aim: Penile cancer (PeCa) is a rare malignancy strongly associated with poor genital hygiene and is more prevalent in regions with low socioeconomic status. PeCa accounts for approximately 2% to 4% of all male cancers in Brazil, with higher incidence in the North and Northeast regions. Despite its aggressive nature, the molecular mechanisms underlying PeCa remain poorly understood. We performed whole-exome sequencing in a Brazilian cohort of patients with PeCa to identify potentially pathogenic genetic alterations associated with tumor development and progression.

Methods: Tumor tissue samples were obtained from patients diagnosed with PeCa. DNA was extracted and subjected to whole-exome sequencing. Human papillomavirus (HPV) genotyping was performed for subtypes 16 and 18. Control samples were collected from individuals without PeCa or other genital diseases.

Results: The cohort demonstrated considerable genetic heterogeneity. Multiple gene mutations were identified in tumor samples, many of which are involved in carcinogenesis-related biological pathways. Distinct molecular profiles were observed, suggesting diverse tumorigenic mechanisms. MUC16 (present in 11/12 patients, 91.7%) and PABPC1 (8/12 patients, 66.7%) were the most frequently mutated genes. HPV-16 was detected in a subset of cases; however, no consistent association with more aggressive disease was identified.

Conclusions: This study provides new insights into the genomic landscape of PeCa in a Brazilian population. The findings highlight the presence of heterogeneous and potentially pathogenic mutations, reinforcing the need for further molecular characterization and exploration of novel therapeutic targets in PeCa.

Keywords

Penile cancer / mutations / epidemiology

Cite this article

Download citation ▾
Renato Mendes Rossi De Lucca, Danielle Barbosa Brotto, Claudia Tarcila Gomes Sares, Kelly Gomes Duarte, Wilson Araujo Silva Junior, Philippe E. Spiess, Shahrokh F. Shariat, Natália Dalsenter Avilez, Caio de Oliveira, Leonardo O. Reis, Rodolfo Borges dos Reis. Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort. Exploration of Targeted Anti-tumor Therapy, 2025, 6 (1) : 1002323 DOI:10.37349/etat.2025.1002323

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Chaux A, Netto GJ, Rodríguez IM, Barreto JE, Oertell J, Ocampos S, et al. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol. 2013; 31: 861-7.

[2]

International Agency for Research on Cancer (IARC). Cancer Incidence in Five Continents Volume XII [Internet]. IARC; c2025 [cited 2025 May 1]. Available from: https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Scientific-Publications/Cancer-Incidence-In-Five-Continents-Volume-XII-2024

[3]

de Oliveira Santos M, da Silva de Lima FC, Martins LFL, Oliveira JFP, de Almeida LM, de Camargo Cancela M. Estimated Cancer Incidence in Brazil, 2023-2025. Rev Bras Cancerol. 2023; 69: e-213700.

[4]

World Health Organization. Predictions of the future cancer incidence and mortality burden worldwide up until 2050 [Internet]. IARC; c 1965-2025 [cited 2025 May 1]. Available from: http://gco.iarc.fr/tomorrow/home

[5]

Ficarra V, Akduman B, Bouchot O, Palou J, Tobias-Machado M. Prognostic factors in penile cancer. Urology. 2010; 76: S66-73.

[6]

Ferreira U, Ribeiro MA, Reis LO, Prudente A, Matheus WE. Sentinel lymph node biopsy in penile cancer: a comparative study using modified inguinal dissection. Int Braz J Urol. 2008; 34: 725-30: discussion 730.

[7]

Machado RD, Faria EF, Júnior AAR, Stirpari F, Feres RN, Spiess PE, et al. Is body mass index a risk factor for lymphnode metastasis in penile cancer? BMC Cancer. 2025; 25: 394.

[8]

Tobias-Machado M, Ornellas AA, Hidaka AK, Medina LG, Mattos PAL, Besio RS, et al. Long-term oncological and surgical outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) in patients with penile cancer. Int Braz J Urol. 2023; 49: 580-9.

[9]

Sachdeva A, McGuinness L, Zapala Ł, Greco I, Garcia-Perdomo HA, Kailavasan M, et al. Management of Lymph Node-positive Penile Cancer: A Systematic Review. Eur Urol. 2024; 85: 257-73.

[10]

Benjamin DJ, Hsu RC. Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy. Front Oncol. 2025; 14: 1457006.

[11]

Flaherty A, Kim T, Giuliano A, Magliocco A, Hakky TS, Pagliaro LC, et al. Implications for human papillomavirus in penile cancer. Urol Oncol. 2014; 32: 53.

[12]

Truzzi JC, da Silva ID, Freire MP, Neto MJ, Rodrigues FF, Maciel GA, et al. Contemporary human papillomavirus genotyping and correlations to peniscopy, cytology, and histopatology on over 1000 males. Diagn Cytopathol. 2020; 48: 1021-6.

[13]

Gai M, Bo Q, Qi L. Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer. Biochem Biophys Res Commun. 2016; 469: 1000-5.

[14]

Lam HC, Nijmeh J, Henske EP. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol. 2017; 241: 219-25.

[15]

Kida Y, Yamaguchi K, Suzuki H, Kanda E, Ando M, Ohashi K, et al. Tuberous sclerosis, associated with renal cell carcinoma and angiomyolipoma, in a patient who developed endstage renal failure after nephrectomy. Clin Exp Nephrol. 2005; 9: 179-82.

[16]

Chen HY, Chen RH. Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications. Front Oncol. 2016; 6: 113.

[17]

Saito Ramalho A, Dantas Lopes A, Talans A, Parlato Sakiyama BY, Stelko Pereira GL, Hoff PM, et al. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (review). Oncol Rep. 2010; 24: 1419-26.

[18]

Ali SM, Pal SK, Wang K, Palma NA, Sanford E, Bailey M, et al. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. Oncologist. 2016; 21: 33-9.

[19]

Zhou QH, Deng CZ, Li ZS, Chen JP, Yao K, Huang KB, et al. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines. Cell Death Dis. 2018; 9: 684.

[20]

Gridley T. Notch signaling in vascular development and physiology. Development. 2007; 134: 2709-18.

[21]

Yang ES, Willey CD, Mehta A, Crowley MR, Crossman DK, Chen D, et al. Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets. Oncotarget. 2017; 8: 21710- 8.

[22]

Agarwal A, Nassar A, Nagy R, Curran C, Abou Alaiwi S, McGregor BA, et al. Genomic landscape of circulating tumor (ct)-DNA alterations in patients with penile cancer. J Clin Oncol. 2019; 37: e16027.

[23]

Loong HH, Raymond VM, Shiotsu Y, Chua DTT, Teo PML, Yung T, et al. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia. Clin Lung Cancer. 2018; 19: e601-8.

[24]

Choi Y, Kwon CH, Lee SJ, Park J, Shin JY, Park DY. Integrative analysis of oncogenic fusion genes and their functional impact in colorectal cancer. Br J Cancer. 2018; 119: 230-40.

[25]

Pylkäs K, Vuorela M, Otsukka M, Kallioniemi A, Jukkola-Vuorinen A, Winqvist R. Rare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression network. PLoS Genet. 2012; 8: e1002734.

[26]

Kusano H, Togashi Y, Akiba J, Moriya F, Baba K, Matsuzaki N, et al. Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene. Am J Surg Pathol. 2016; 40: 761-9.

[27]

Lin AC, Roche AE, Wilk J, Svensson EC. The N termini of Friend of GATA (FOG) proteins define a novel transcriptional repression motif and a superfamily of transcriptional repressors. J Biol Chem. 2004; 279: 55017-23.

[28]

Bond HM, Scicchitano S, Chiarella E, Amodio N, Lucchino V, Aloisio A, et al. ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer. Front Endocrinol (Lausanne). 2018; 9: 255.

[29]

Huang HT, Chen SM, Pan LB, Yao J, Ma HT. Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer. Oncol Rep. 2015; 33: 283-91.

[30]

Sattar M, Majid A. Lung cancer classification models using discriminant information of mutated genes in protein amino acids sequences. Arab J Sci Eng. 2019; 44: 3197-211.

[31]

Yamagishi H, Kuroda H, Imai Y, Hiraishi H. Molecular pathogenesis of sporadic colorectal cancers. Chin J Cancer. 2016; 35: 4.

[32]

Frankum J, Moudry P, Brough R, Hodny Z, Ashworth A, Bartek J, et al. Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity. Oncotarget. 2015; 6: 10746-58.

[33]

Petrochilos D, Shojaie A, Gennari J, Abernethy N. Using random walks to identify cancer-associated modules in expression data. BioData Min. 2013; 6: 17.

[34]

Trafalis DT, Alifieris CE, Kalantzis A, Verigos KE, Vergadis C, Sauvage S. Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma. J Immunother. 2018; 41: 300-5.

[35]

Maluf FC, Trindade K, Almeida Preto DD, Monteiro FSM, Luz M, Beato PM, et al. A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. J Clin Oncol. 2024; 42: 5009.

[36]

Carthon BC, Ng CS, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis. BJU Int. 2014; 113: 871-7.

[37]

Pagliaro LC, Tekin B, Gupta S, Herrera Hernandez L. Therapeutic Targets in Advanced Penile Cancer: From Bench to Bedside. Cancers (Basel). 2024; 16: 2086.

PDF (786KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉